We are live on
!
Find out more
GWCM
Godshalk Welsh Capital Management Portfolio holdings
AUM
$172M
1-Year Est. Return
16.03%
This Fund
S&P 500
This Quarter
Est. Return
+3.62%
1 Year Est. Return
+16.03%
3 Year Est. Return
+54.69%
5 Year Est. Return
+73.83%
10 Year Est. Return
+285.54%
AUM
$142M
AUM Growth
+$4.56M
(+3.3%)
Cap. Flow
+$1.67M
Cap. Flow
% of AUM
1.18%
Top 10 Holdings %
Top 10 Hldgs %
29.33%
Holding
119
New
6
Increased
27
Reduced
45
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WOW
WideOpenWest
WOW
|
+$933K |
| 2 |
iShares Short-Term National Muni Bond ETF
SUB
|
+$449K |
| 3 |
iShares National Muni Bond ETF
MUB
|
+$321K |
| 4 |
Fidelity High Dividend ETF
FDVV
|
+$294K |
| 5 |
Citigroup
C
|
+$221K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$275K |
| 2 |
Honeywell
HON
|
+$220K |
| 3 |
Microsoft
MSFT
|
+$156K |
| 4 |
Invesco Preferred ETF
PGX
|
+$126K |
| 5 |
Apple
AAPL
|
+$107K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.48% |
| 2 | Healthcare | 13.36% |
| 3 | Consumer Staples | 11.74% |
| 4 | Financials | 10.95% |
| 5 | Consumer Discretionary | 6.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Hershey
HSY
$36.6B
| $534K | 0.38% |
2,100
| – | – |
|
77
DuPont de Nemours
DD
$19.3B
| $532K | 0.38% |
5,903
| – | – |
|
78
Invesco QQQ Trust
QQQ
$481B
| $521K | 0.37% |
1,622
-50
| -3% | -$14.8K |
|
79
International Flavors & Fragrances
IFF
$21.6B
| $514K | 0.36% |
5,588
+10
| +0.2% | +$994 |
|
80
Quest Diagnostics
DGX
$26.2B
| $509K | 0.36% |
3,600
-25
| -0.7% | -$3.58K |
|
81
Consolidated Edison
ED
$39.9B
| $507K | 0.36% |
5,300
-100
| -2% | -$9.37K |
|
82
MetLife
MET
$61.5B
| $492K | 0.35% |
8,500
| – | – |
|
83
Intel
INTC
$507B
| $470K | 0.33% |
14,374
-450
| -3% | -$12.7K |
|
84
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.59B
| $456K | 0.32% |
8,350
| – | – |
|
|
85
iShares Short-Term National Muni Bond ETF
SUB
$11.4B
| $450K | 0.32% |
+4,300
| New | +$449K |
|
86
Clorox
CLX
$12.9B
| $447K | 0.32% |
2,825
| – | – |
|
87
Corning
GLW
$143B
| $412K | 0.29% |
11,675
+900
| +8% | +$31.3K |
|
88
iShares Core S&P US Growth ETF
IUSG
$33.7B
| $403K | 0.28% |
4,545
| – | – |
|
89
Bristol-Myers Squibb
BMY
$131B
| $399K | 0.28% |
5,750
-100
| -2% | -$7.05K |
|
90
Danaher
DHR
$145B
| $397K | 0.28% |
1,777
| – | – |
|
91
Abbott
ABT
$191B
| $347K | 0.24% |
3,422
-85
| -2% | -$8.97K |
|
92
Mastercard
MA
$488B
| $345K | 0.24% |
950
| – | – |
|
93
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.74B
| $344K | 0.24% |
6,873
+648
| +10% | +$31.9K |
|
94
Masco
MAS
$14.7B
| $336K | 0.24% |
6,750
-500
| -7% | -$25.8K |
|
|
95
iShares National Muni Bond ETF
MUB
$45.9B
| $323K | 0.23% |
+3,000
| New | +$321K |
|
96
Republic Services
RSG
$66.3B
| $304K | 0.21% |
2,250
-50
| -2% | -$6.38K |
|
97
Elevance Health
ELV
$85.4B
| $299K | 0.21% |
650
| – | – |
|
98
BHP
BHP
$231B
| $298K | 0.21% |
4,700
| – | – |
|
|
99
Fidelity High Dividend ETF
FDVV
$10.4B
| $291K | 0.21% |
+7,650
| New | +$294K |
|
100
Uber
UBER
$155B
| $284K | 0.2% |
8,950
| – | – |
|
Similar funds
TA
CRFG
BAM
RPSM
BIA
SPF
KIM
AIM
Godshalk Welsh Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Godshalk Welsh Capital Management held 119 positions worth $142M, up 3.3% from $137M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Godshalk Welsh Capital Management's Q1 2023 filing shows 6 new, 27 increased, 45 reduced and 1 closed positions. Its largest new stake was iShares Short-Term National Muni Bond ETF: 4,300 shares worth $450K. The largest sale was Pfizer, an estimated $275K.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Staples.
- Godshalk Welsh Capital Management's largest Q1 2023 buy was iShares Short-Term National Muni Bond ETF: 4,300 shares worth $450K.
- Godshalk Welsh Capital Management added most to WideOpenWest in Q1 2023, an estimated $933K increase.
- Godshalk Welsh Capital Management's biggest Q1 2023 reduction was Pfizer, cutting an estimated $275K.
- Godshalk Welsh Capital Management fully exited Honeywell in Q1 2023, selling an estimated $220K.
- Godshalk Welsh Capital Management's ten largest holdings make up 29% of its $142M portfolio in Q1 2023.
- Godshalk Welsh Capital Management opened 6 new positions and closed 1 in Q1 2023.
- Godshalk Welsh Capital Management's portfolio value rose 3.3% quarter-over-quarter to $142M.
Based on Godshalk Welsh Capital Management's 13F filing for Q1 2023, filed 12 May 2023.